A new collaborative study from the University of Eastern Finland, Washington University in St. Louis, University of Wisconsin–Madison, University of North Carolina at Chapel Hill and the Promega Corporation discloses the discovery and application of a new chemical probe to selectively inhibit human COQ8A in cells. The results were published in Nature Chemical Biology.
Click here for original story, The first potent COQ8 inhibitor targets ubiquinone biosynthesis
Source: Phys.org